血管压缩剂对猪葡萄糖初始分布体积的影响
Kohei Noto1, Eiji Hashiba2, Satoshi Uchida3
1Department of Anesthesiology, Hirosaki University Postgraduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8563, Japan. notokhi@hirosaki-u.ac.jp.
Journal of anesthesia
|February 10, 2026
概括
葡萄糖的初始分布体积 (IDVG) 反映了中央细胞外液体 (ECF) 体积的变化. 血管收缩剂如诺拉丁上腺素和血管压素在败血性休克中不同地影响IDVG,影响ECF体积和静脉回流.
科学领域:
- 生理学和病理生理学
- 心血管研究研究心血管研究
- 细胞外流体动力学 细胞外流体动力学
背景情况:
- 葡萄糖的初始分布体积 (IDVG) 是中央细胞外液体 (ECF) 体积的一个建议指标.
- 血管缩剂对IDVG的影响,特别是在败血症中,仍然不完全理解.
- 了解这些影响对于管理严重疾病中的液体平衡和血液动力学至关重要.
研究的目的:
- 为了研究诺亚上腺素和氨酸压缩素 (AVP) 对猪的IDVG的影响.
- 为了在正常生理条件下和在脂聚糖 (LPS) 诱导的败血症休克期间检查这些影响.
- 为了澄清IDVG,心脏输出 (CO) 和静脉缩剂治疗期间的中央心电体积之间的关系.
主要方法:
- 十二只麻醉后的猪接受了血液动力学监测.
- 在静脉注射葡萄糖后,使用单间模型测量IDVG.
- 诺拉丁上腺素和AVP被用于调节非败血和LPS诱导的败血状态的血压;CO和IDVG指数被评估.
主要成果:
- 在非败血性猪中,诺拉上腺素增加了CO和IDVG指数,而AVP则降低了这两种指数.
- 在非败菌动物中,IDVG指数和CO之间观察到强烈的正相关性 (r=0.74).
- 在败血症猪中,诺拉丁上升了CO,但没有IDVG指数;AVP降低了IDVG指数,但没有影响CO. IDVG指数和CO之间存在强烈的正相关性 (r=0.76).
结论:
- IDVG似乎反映了与静脉回归相关的中央ECF体积变化,即使在服用血管收缩剂时也是如此.
- 这些发现表明,IDVG在毒症中血管缩剂治疗期间监测液体状况的潜在实用性.
- 诺拉上腺素和AVP对IDVG的差异性影响突出了败血症休克中流体动态的复杂性.
相关概念视频
Volume of Distribution
1.3K
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
1.3K
Drug Distribution: Volume of Distribution
7.5K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
7.5K
Initiation of Translation
39.2K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.2K
Initiation of Translation
8.2K
8.2K
Glucose Homeostasis: Regulation of Blood Glucose
4.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.4K
Transcription Initiation
21.3K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.3K


